Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05945602 · ClinicalTrials.gov registry record
Neurophysiologic Biomarkers for Cognitive Rehabilitation
A clinical trial of Schizophrenia Spectrum Disorders, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT05945602 is a study of Schizophrenia Spectrum Disorders that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05945602, a study of Schizophrenia Spectrum Disorders, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Cognitive symptoms of schizophrenia interfere with daily life-from managing self-care, to more complex tasks like taking medications and living independently. Unfortunately, these cognitive symptoms are not corrected by 'standard of care' treatments (antipsychotic medications), although some schizophrenia patients may experience modest clinical and cognitive benefits from cognitive remediation. To enhance the clinical impact of cognitive remediation and other rehabilitative interventions for Veterans living with chronic psychosis, this study will develop novel brain-based tools to help identify those Veterans who are most likely to benefit from pro-cognitive therapies. These studies may advance predictive algorithms that improve functional outcomes and life quality in Veterans with schizophrenia.
Conditions Studied
Interventions
- OTHER Neurophysiologic Biomarker Assessments
Study Locations (1)
California
- VA San Diego Healthcare System, San Diego, CA - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2028-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05945602
The ClinicalTrials.gov registry entry for NCT05945602 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Schizophrenia Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Neurophysiologic Biomarker Assessments is the first listed.
NCT05945602 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05945602 about?
NCT05945602 is a clinical study titled "Neurophysiologic Biomarkers for Cognitive Rehabilitation". Cognitive symptoms of schizophrenia interfere with daily life-from managing self-care, to more complex tasks like taking medications and living independently. Unfortunately, these cognitive symptoms are not corrected by 'standard of care' treatments (antipsychotic medications), although some schizop...
What is the current status of trial NCT05945602?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2023-10-01. Estimated completion is 2028-09-30.
What conditions does trial NCT05945602 study?
This clinical trial studies the following conditions: Schizophrenia Spectrum Disorders.
What interventions are being tested in trial NCT05945602?
The interventions under investigation include: Neurophysiologic Biomarker Assessments (OTHER).
Who is sponsoring clinical trial NCT05945602?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05945602 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.